Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,900
Closed -$779K 20
2023
Q3
$779K Buy
+2,900
New +$724K 0.47% 27
2023
Q1
Sell
-2,900
Closed -$762K 27
2022
Q4
$762K Sell
2,900
-2,000
-41% -$536K 0.38% 97
2022
Q3
$1.1M Sell
4,900
-100
-2% -$24.2K 0.81% 32
2022
Q2
$1.22M Buy
+5,000
New +$1.23M 0.81% 29
2021
Q2
Sell
-3,700
Closed -$921K 22
2021
Q1
$921K Buy
+3,700
New +$883K 0.08% 111
2020
Q4
Sell
-4,000
Closed -$1.02M 27
2020
Q3
$1.02M Buy
+4,000
New +$991K 0.31% 24

Other funds holding AMGN

Toews Corporation's AMGN Position: Q4 2023 in Review

Toews Corporation sold out of Amgen (AMGN) in Q4 2023, closing a stake of 2,900 shares — an estimated $779K sold.

Toews Corporation first reported a position in AMGN in Q3 2020 and held it in 6 quarters. The position peaked at $1.22M in Q2 2022. 2,714 funds tracked by Wall St. Rank hold AMGN as of Q4 2023.

  • Toews Corporation reported no remaining Amgen position as of Q4 2023 after selling out during the quarter.
  • Toews Corporation sold 2,900 Amgen shares in Q4 2023, an estimated $779K.
  • Toews Corporation first reported a position in Amgen in Q3 2020 and held it in 6 quarters.
  • Toews Corporation's Amgen position peaked at $1.22M in Q2 2022.
  • 2,714 funds tracked by Wall St. Rank held Amgen as of Q4 2023.

Based on Toews Corporation's 13F filing for Q4 2023, filed 17 Jan 2024.